Avioq Employee Directory
Biotechnology ResearchNorth Carolina, United States11-50 Employees
Avioq operates as a biotechnology firm that develops and manufactures in vitro diagnostic tests and also offers contract development and manufacturing services. It is based in Research Triangle Park, North Carolina, and maintains an FDA-licensed manufacturing facility supported by extensive research and development laboratories. Its product portfolio includes an FDA-licensed HTLV-I/II assay for screening serum and plasma from blood donors and cadaveric samples, which also has CE marking and Health Canada approval, as well as an HIV-1 assay with FDA-approved claims across multiple specimen types. Additionally, the HIV Profile assay is an FDA-approved ELISA used to confirm and differentiate antibodies to HIV-1 (Groups M and O) and HIV-2 in serum or plasma, serving as a supplementary, more specific test. The company maintains a mature ISO 13485:2016-certified quality system, and its facility has been inspected by FDA, ISO, and external partners. In 2019, Avioq announced CE Mark and European launch of the VioOne HIV Profile Supplemental Assay.